■ INTRODUCTION
Nucleoside analogues are extensively used as agents in antiviral and antitumor chemotherapy. However, their biological activity is strongly dependent on their intracellular activation by host cell kinases to give, via the mono-and the diphosphate, the ultimately active triphosphate derivative which inhibits the function of the viral DNA polymerase. However, in the case of nucleoside analogues cellular kinases often catalyze these metabolic steps insufficiently. 1, 2 The result might be a partial loss of antiviral activity or for some nucleoside analogues even a complete failure to exhibit any antiviral activity. Moreover, inefficient phosphorylation led in some cases to adverse effects. 3, 4 The use of prodrug forms of phosphorylated nucleoside analogues (pronucleotides) can circumvent rate limiting steps within the metabolic pathway by bypassing at least one, if not several, involved activating enzymes. 5, 6 This task has been successfully achieved in the past for the intracellular delivery of monophosphates of nucleoside analogues using prodrug strategies such as the cycloSal-, 7−9 Sate-, 10, 11 bisPOM- 12 and phosphoramidate-nucleotide approaches. 13, 14 Remarkably, in contrast to numerous examples of successful nucleoside monophosphate prodrug approaches for the bypass of nucleoside kinases, the development of nucleoside diphosphate (NDP) prodrugs has been very rarely addressed. However, such a prodrug approach might be desirable, for instance, in the case of 3′-azido-3′-deoxythymidine (AZT), which is very poorly phosphorylated from AZTMP to yield AZTDP by thymidylate kinase (TMP-K) in human cells. 15, 16 Hostetler et al. synthesized different nucleoside diphosphate diglycerides as potential NDP prodrugs. 17−20 However, the hydrolysis of these compounds delivered the monophosphates instead of the diphosphates as a result of the cleavage of the diphosphate moiety. A second approach was reported by Huynh-Dinh et al. 21−23 In their approach, the β-phosphate was acylated with fatty acids forming a mixed anhydride bond. In chemical hydrolysis studies the NDP was formed. However, in cell extracts an undefined decomposition of the compounds was observed.
Since a few years, we turned our interest toward the bioreversible protection of nucleoside diphosphates although, as compared to nucleoside monophosphate prodrugs, the design of such compounds is more demanding because of a chemical reason. In NDPs, a complete lipophilic modification of the charged and therefore highly polar diphosphate unit led to a considerable decrease in chemical stability of this part of the molecule. As a result, the phosphate anhydride bond of the nucleoside diphosphate was cleaved leading to two monophosphorylated fragments.
Earlier, we reported on the DiPPro approach. In this approach, esterification of the β-phosphate of a NDP with two bis(acyloxybenzyl) moieties neutralizes the charges at this phosphate group. In previous studies this was achieved by masking the β-phosphate using two identical bis-(alkanoyloxybenzyl) 24, 25 or bis(benzoyloxybenzyl) moieties 26 (symmetrical modification, R 1 = R 2 ). The concept was based on an enzyme-driven cleavage of these masking units, which ensured that the release of NDPs preferably took place intracellularly because of the higher concentrations of the esterases/lipases in the target cells. In contrast to the low stability in the presence of esterases, the chemical stability at physiological pH was still found to be high. By choosing the appropriate substituent R in the ester moiety within the mask, it was possible to "tune" both stability and lipophilicity of the prodrugs (Scheme 1). 25 Although we were able to prove that this approach works, an unwanted property of the symmetric aliphatic or aromatic DiPPro compounds was that also some nucleoside monophosphate (NMP) was detected in addition to the wanted nucleoside diphosphate, e.g., in PBS solution, pH 7.3, or cell extract hydrolysis studies. Interestingly, it was shown that the amount of NMP clearly correlated with the stability of the DiPPro compounds and that the stability of the compounds was dependent on the length of the alkyl residues R attached via an ester linkage to the 4-hydroxybenzyl group: the longer the alkyl group R, the higher was the stability of the DiPPro compounds but the higher was also the amount of NMP formed in the chemical hydrolyses and in the cell extract studies. As the reason for the formation of NMP, a concurrence reaction was identified in which water/hydroxide reacted at the phosphorus atom of the β-phosphate group. This led to the cleavage of the phosphate anhydride bond releasing the NMP. This side reaction became more relevant with increasing stability of the ester linkage in the prodrug moiety. On the other hand, we observed that after the removal of the first mask to give a monomasked intermediate such as 2, no further increase of the amount of NMP was observed (Scheme 1). The reason here was that after the first removal an additional charge appeared at the β-phosphate, and this obviously prevented a nucleophilic reaction at this moiety.
Taking all previous results together, these findings led to the development of a second generation of DiPPro compounds. Here, we disclose a study on a series of nonsymmetric DiPPronucleotides 1 bearing two different masking units (R 1 not equal to R 2 ). The design was the following: One masking group contained a short alkyl chain carboxylic acid ester which, because of our previously reported data, 25 will be rapidly cleaved by chemical or enzymatic means. The second masking group contained a long alkyl residue carboxylic acid ester or a substituted benzoic acid ester, which adds high lipophilicity to the molecule. It was expected that such a construct would allow a rapid conversion of the DiPPro compound 1 into the monomasked intermediate 2 and thereby should avoid the side reaction to form the unwanted nucleoside monophosphate. The second mask will be cleaved subsequently from the intermediate to form the nucleoside diphosphate. It was expected that with these nonsymmetric compounds a highly selective conversion of the DiPPro compounds into nucleoside diphosphates can be achieved.
■ RESULTS AND DISCUSSION
Synthesis. For the synthesis of nonsymmetric DiPProNDPs 1, we first tried to use the protocol of the symmetric counterparts. 24−26 According to that protocol, an amount of 2 equiv of an appropriate 4-acyloxybenzyl alcohol was reacted with dichloro-N,N-diisopropylaminophosphoramidite to give the corresponding phosphoramidite like 5 (R 1 = R 2 ) which was then coupled by an acid-mediated reaction with a nucleoside monophosphate followed by oxidation. For the new nonsymmetric compounds an attempt was made to introduce two different 4-acyloxybenzyl masking units 3 and 4 by the same way. However, this approach failed. 
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Article Finally, in a new protocol 4-acyloxybenzyl alcohol 3 was reacted with phosphorus trichloride followed by the addition of 2 equiv of N,N-diisopropylamine (DIPA) which led to bis(diisopropylamino)phosphoramidites 6 in yields up to 56% in a one-pot reaction. Then, one of the diisopropylamino moieties was replaced by the second 4-acyloxybenzyl alcohol 4 after activation with dicyanoimidazol (DCI) to yield the nonsymmetric phosphoramidites 5 in very high yields.
Next, a second acid-activated coupling of these phosphoramidites 5 with the corresponding nucleoside monophosphates was carried out. At the beginning, the conversions obtained in this coupling reaction were surprisingly low, which was proven by NMR and HPLC analyses of the crude mixtures. Changing the equivalents of phosphoramidite 5 and the DCI activator did not led to an improvement. Finally, the problem was solved by the successive addition of small amounts of the DCI-activator solution. Starting with the addition of 0.5 equiv of DCIactivator solution to a solution of 1 equiv of the nucleoside monophosphate and 1.5 equiv of the phosphoramidite 5, followed by the stepwise addition of 0.25 equiv every 5 min up to a total of 1.25 or 1.75 equiv of DCI led to a quantitative conversion of the nucleotide. DiPPro-nucleotides 7−10 were successfully isolated by using automated flash RP-18-chromatography. By use of the new protocol, numerous combinations of DiPPro-nucleotides were accessible in quantitative conversions, high isolated yields, and high purity, which was checked by means of 1 H, 13 C, and 31 P NMR spectroscopy, mass spectrometry, and HPLC analysis. The route for the synthesis of nonsymmetric DiPPro-NDPs 7−10 is summarized in Scheme 2.
Structural formulas of DiPPro-d4TDPs 7, 8 and DiPProAZTDPs 9, 10 bearing different aliphatic (R 2 = C n H 2n+1 ) and aromatic (R 2 = X-Ph) acyl moieties as the lipophilic masks in combination with short aliphatic acyl moieties (R 1 = CH 3 , C 4 H 9 ) in the acyloxybenzyl-masking group are summarized in Figure 1 . Also three symmetric DiPPro-AZTDPs 11a−c were prepared by the earlier published method.
Hydrolysis Studies. All prepared compounds were studied with regard to their stabilities and their hydrolysis products in different media.
Chemical Stability in Phosphate Buffer, pH 7.3. We expected that the more labile mask would be cleaved faster to form intermediate 2 bearing the long, lipophilic, and hydrolytically more stable mask. However, surprisingly in the chemical hydrolysis studies in most of the cases both intermediates were observed by means of HPLC analysis. In the monomasked intermediates 2, the short alkanoyl ester moieties were more rapidly hydrolyzed as compared to the long alkyl bearing moieties. Furthermore, the half-lives determined in phosphate buffer, pH 7.3, of the nonsymmetric DiPPro compounds were surprisingly higher as compared to those of the symmetric DiPPro-NDPs. This can be seen for example for compound 7b (CH 3 /C 9 H 19 -DiPPro-d4TDP). In this case the half-life of the cleavage of the first masking group bearing the acetate group was 40 h while the same masking group in the symmetrical di-CH 3 -DiPPro-d4TDP was cleaved with a half-life of 10 h only. 24 Steric hindrance or aggregation due to the second, more lipophilic moiety might be a reason for this increase in stability. The determined half-lives of the formation of the monomasked intermediate were between 15 and 69 h as summarized in Table 1 .
The chemical stabilities of DiPPro-AZTDPs 9, 10 were in the same range as those of the DiPPro-d4TDPs 7, 8 having identical prodrug moieties. Only CH 3 /C 11 H 23 -DiPPro-AZTDP 9c showed a lower stability compared to the corresponding d4TDP derivative 7c for some unknown reasons. Even in comparison with the DiPPro compounds with shorter alkyl chains the stability of CH 3 /C 11 H 23 -DiPPro-AZTDP 9c was markedly low. Nevertheless, all DiPPro compounds 7−10 hydrolyzed in buffer to form almost exclusively the nucleoside diphosphate.
As reported before, some NMP was formed as well probably because of the unexpected high hydrolytic stability compared to the symmetric DiPPro compounds bearing short alkyl chains in the masking group. It is important to mention that the ratio of NDP to NMP in these chemically driven hydrolyses was higher as described for the symmetric compound with longer chains. 24, 25 We also evaluated the chemical stability of DiPPro-AZTDP 9b and 10b in Roswell Park Memorial Institute (RPMI) medium in addition to PBS solution, pH 7.3, as described above. Both compounds showed also under these conditions high stability (t 1/2 = 19 h for 9b and t 1/2 = 77 h for 10b) and were found to be markedly more stable as compared to the CEM/0 cell extracts.
Incubations in Cell Extracts of Wild Type CD 4 + TLymphocyte Cells (CEM/0 Cell Extracts). As in the abovedescribed studies in PBS and RPMI culture medium, the halflives of the DiPPro compounds were found to be independent of the nucleoside analogue attached to the molecule. In contrast to the chemical hydrolysis studies, the prodrugs delivered the corresponding nucleoside diphosphate selectively within 2−7 h only. In the case of the CH 3 /R 2 -DiPPro-NDPs 7 and 9 the hydrolysis led exclusively to the intermediates bearing the long lipophilic acyl group with half-lives of minutes (Table 1) . In all cases the acetate ester was selectively cleaved first. However, in comparison the cell extract hydrolysis of the C 4 H 9 /R 2 -DiPProNDPs 8 and 10 released in addition to the intermediate bearing the long alkyl chain acyl group also the C 4 H 9 intermediate, although in a markedly smaller ratio. This is due to the higher stability of the pentanoyl (R 1 = C 4 H 9 ) ester moiety compared to the acetate group present in compounds 7 and 9. But also in these cases the diphosphate was finally formed from both intermediates selectively. The more lipophilic mask had no influence on the half-lives of the cleavage of the short chain acyl group (R 1 = CH 3 and R 1 = C 4 H 9 , respectively, Table 1 ) except for the four DiPPro-nucleotides with R 2 = C 11 H 23 (7c−10c) which showed different stabilities. Figure 2 summarizes as an example the hydrolysis of CH 3 /C 9 H 19 -DiPPro-d4TDP 7b in CEM/0 cell extracts followed by means of RP-18 HPLC. After 60 min virtually all of the prodrug 7b was consumed. Only the C 9 H 19 intermediate 11b and d4TDP appeared as hydrolysis products at that time point. Whether traces of d4TMP were also formed remained unclear because the detection of d4TMP was not possible by RP-18 HPLC because of remaining cell extract components that eluted in the chromatogram with identical retention time. On the other hand, by use of a HILIC column (HILIC: hydrophilic interaction liquid chromatography) in the chromatography, the separation of d4TMP from cell extract components was successful. With this second analytical method it was proven that very small amounts of d4TMP were also present in the CEM cell extract hydrolysis samples of the DiPPro compounds.
In order to study if the detected d4TMP resulted either from the side reaction described above or from a dephosphorylation of d4TDP to give d4TMP due to phosphatases present in the extracts, both d4TDP and AZTDP were incubated as well in the CEM/0 cell extracts and aliquots of the hydrolysis mixtures were analyzed after 2, 4, 7, and 10 h of incubation. In both cases d4TMP and AZTMP were detected. The half-life of dephosphorylation of d4TDP was 10 h, while that of AZTDP was 19 h in the experimental setup. For this reason, we concluded that the trace amounts of the nucleoside monophosphates found in the above-described hydrolysis studies of the DiPPro compounds in CEM/0 cell extracts were most likely a result of a dephosphorylation of the formed diphosphates from the prodrugs.
In the case of the C 4 H 9 /R 2 -DiPPro-nucleotides 8 and 10 the hydrolysis proceeded via both possible intermediates and then led to the corresponding NDPs. As the half-lives for the starting DiPPro compounds 1 bearing an acetyl (R 1 = CH 3 ) or a pentanoyl (R 1 = C 4 H 9 ) residue, the half-lives for the formed monomasked intermediates of type 2 were dependent on the acyl ester group. The half-lives of monomasked intermediates were determined by the decrease of the corresponding peak areas in the HPL-chromatograms of these compounds in the hydrolysis mixtures of the CH 3 /R 2 -DiPPro-nucleotides 7 and 9 in CEM/0 cell extracts after full consumption of the starting DiPPro compounds. The results are summarized in Table 2 .
We assumed that the stability would increase with longer chain length. Interestingly, intermediates 2a and 2′a were more stable than the ones with longer chain length. Therefore, it Incubations with Pig Liver Esterase. The nonsymmetric aliphatic DiPPro-AZTDPs 9a−c and 10a−c bearing a R 1 = CH 3 or C 4 H 9 in combination with long alkyl chains as the R 2 residue were incubated with pig liver esterase (PLE) to investigate the influence of the chain length on the enzymatic cleavage by this esterase. Furthermore, CH 3 /C 9 H 19 -DiPPro-d4TDP 7b and C 4 H 9 /C 9 H 19 -DiPPro-d4TDP 8b were also included to study whether the attached nucleoside analog has an effect on the hydrolysis pathway or on the compound stability.
The results of the hydrolysis experiments in the presence of PLE are summarized in Table 3 .
All compounds were rapidly hydrolyzed and delivered the nucleoside diphosphates d4TDP or AZTDP exclusively within a few minutes. The half-lives determined for the CH 3 /C 7 H 15 and CH 3 /C 9 H 19 compounds 9a,b as well as the C 4 H 9 /C 7 H 15 and C 4 H 9 /C 9 H 19 -masked pronucleotides 10a,b were found to be all in the same range (0.21−0.27 min). The influence of the nucleoside on the half-live was small, although DiPPro-d4TDPs 7b and 8b proved to be somewhat less stable. In contrast, both compounds 9c, and 10c (CH 3 /C 11 H 23 -and C 4 H 9 /C 11 H 23 -DiPPro-AZTDP) bearing the longest aliphatic chain showed higher stability against hydrolysis by PLE.
Remarkably, in the case of the hydrolysis of all CH 3 /R 2 -DiPPro 9a−c, 7b, exclusively the hydrolysis intermediate bearing the long aliphatic chain was formed although in very small amounts. Therefore, it was not possible to determine the half-lives of these intermediates from the hydrolysis mixtures. This means that both alkanoyl esters were cleaved at almost identical rates, although with a slight preference of the C 1 -alkanoyl group. As an example, the HPL-chromatograms of the incubations of compound 9b with PLE are shown in Figure 3 .
In contrast, incubation of C 4 H 9 /R 2 -DiPPro-NDPs 10a−c, 8b with PLE initially showed high amounts of the C 4 H 9 -intermediate ( Figure 4 , e.g., the 1 min HPLC chromatogram). In addition, as for the C 7 H 15 and C 11 H 23 intermediate, the C 9 H 19 -chain bearing intermediate 2′b was also detected in the HPL-chromatograms although to a minor extent. In contrast to the above study with the CH 3 -bearing DiPPro compounds, here obviously the longer lipophilic chain acyl groups are cleaved faster than the C 4 H 9 -alkanoyl ester. This can be concluded from the markedly different amounts of the two possible intermediates in the HPL-chromatograms (Figure 4) . From both formed intermediates AZTDP was finally released with a half-life of about 19 min as the sole hydrolysis product.
These observations contrasted also with the results obtained in CEM/0 cell extracts and point to a different substrate 
Article specificity of the esterase from pig liver and the esterases present in human CEM/0 cells or other enzymes that play a significant role in the hydrolysis process of the DiPPro compounds described here.
Comparative Hydrolysis Studies. Finally, we compared the nonsymmetric DiPPro-nucleotides described here with compounds 11 bearing identical masking groups. Therefore, nonsymmetric and the symmetric counterparts DiPPro-AZTDP derivatives with R = C 4 H 9 (11a), C 6 H 13 (11b), and C 9 H 19 (11c) were incubated in phosphate buffer at pH 7.3 and in CEM/0 cell extracts. The hydrolysis studies in PBS led to significant differences in the ratios of formed NDP and NMP. In all cases the symmetric compounds 11 formed markedly more NMP and less NDP as compared to the studies of the nonsymmetric DiPPro compounds disclosed here. Even more interesting was the comparison of the hydrolysis in CEM/0 cell extracts. Also under these conditions the hydrolysis of the symmetric C 4 H 9 -DiPPro-AZTDP 11a and C 6 H 9 -DiPPro-AZTDP 11b resulted in high NDP/NMP ratios. In contrast, this ratio decreased significantly in the case of the more lipophilic C 9 H 19 -DiPPro-AZTDP 11c which was correlated to the difference in the rate of metabolism. As mentioned above, the short chain alkyl esters are rapidly cleaved by the esterases present in the extracts, and therefore, the side reaction did not interfere as in the case of the more stable long chain aliphatic esters. Figure 5 summarizes a comparison of the hydrolysis of CH 3 /C 9 H 19 -DiPPro-AZTDP 9b, C 9 H 19 -DiPPro-AZTDP 11c, and the nucleoside diphosphate AZTDP after 10 h of incubation. The analysis of the hydrolysis aliquots was performed by means of HILIC-HPLC. The NDP/NMP ratio in the case of the nonsymmetric prodrug 9b was found to be 5:1. For the symmetric prodrug 11c the ratio was only 1.5:1. Interestingly, starting from independently synthesized AZTDP, the ratio was found to be 3:1 after 10 h of incubation in CEM/0 cell extracts.
The markedly higher ratio found in the case of the nonsymmetric DiPPro-prodrug 9b compared to AZTDP implies that compound 9b is not susceptible to cleavage at the pyrophosphate moiety. The formation of the NMP only took place by the enzymatic dephosphorylation af ter AZTDP delivery and thus after cleavage of the masking units. As a consequence, the NDP/NMP ratio in the case of the prodrug 9b was even higher as compared to that of AZTDP for which the dephosphorylation immediately starts at the beginning of the incubation. On the other hand, because of the high stability of the symmetric DiPPro compound 11c against enzymatic cleavage of the prodrug moieties, the chemical cleavage of the diphosphate unit in this compound occurred by the abovedescribed concurrence reaction which led to AZTMP and consequently to a low NDP/NMP ratio (1.5:1). Antiviral Activity. All DiPPro compounds 7−11 were evaluated for their anti-HIV activity in HIV-1-and HIV-2-infected wild-type CEM/0 cell cultures and in HIV-2-infected 
Article mutant thymidine kinase-deficient CEM/TK − cell cultures. Table 4 summarizes the antiviral and cytostatic data of the DiPPro compounds 7−10 and the parent nucleoside analogues d4T and AZT, respectively, as reference compounds.
D4TDP derivatives 7, 8 bearing aliphatic ester functions in the acyloxybenzyl units (a−c) proved to be antivirally active against HIV-1 and HIV-2 at least in the same concentration range as compared to the parent compound d4T in wild-type CEM/0 cell cultures. Often the inhibitory potency was even somewhat higher as compared to that of the parent nucleoside particularly for compound 8c. The antiviral activity observed in the wild-type CEM/0 cell cultures was completely retained in the case of the lipophilic DiPPro compounds 7b and 8b,c in mutant thymidine-deficient CEM cells (TK − ). Moreover, the antiviral activity increased with the increase of lipophilicity associated with the introduced acyl moieties of the DiPPro prodrugs.
Disappointingly, DiPPro-d4TDPs 7, 8 bearing benzoyl ester functions in the masking units (d, e) proved to be less potent as compared to the alkanoyl counterparts. They also were less active as compared to d4T in the wild-type CEM/0 cell cultures and lost more or less all antiviral activity in the TK-deficient CEM cell cultures (EC 50 ≥ 10 μM).
Like the d4TDP-containing DiPPro compounds, the AZTDP derivatives 9 and 10 were able to inhibit the HIV-1 and HIV-2 induced cytopathogenic effect at very low concentrations in wild-type CEM/0 cell cultures.
In mutant thymidine kinase-deficient CEM/TK − cell cultures only the lipophilic compounds 9c, 10b, and 10c showed some antiviral activity (EC 50 ≈ 10 μM). Interestingly, the symmetric C 9 H 19 -DiPPro compound 11c was active at 1.3 μM in the TKdeficient CEM cell cultures. One reason for this pronounced retention of antiviral activity of 11c might be that the lipophilicity of this compound was sufficiently high to allow a passage through the cell membrane. In the hydrolysis studies discussed above it was shown that all compounds bearing an acetyl ester as an acyl moiety in the masking group were cleaved extremely fast. Thus, if these compounds are not lipophilic enough, they will be cleaved in the cell culture medium before the uptake into the cells. Then AZTDP will be formed extracellularly which will be enzymatically dephosphorylated to give AZT. AZT is able to migrate through the membrane, and this results in antiviral activity in the wild-type cell cultures. It has been reported that the phosphorylation of AZTMP to AZTDP by dTMP kinase is rate-limiting. 15, 16 However, another reason for the failure of the DiPPro-AZTDP compounds might be that even the delivered AZTDP is not efficiently metabolized into the corresponding triphosphate. In such a case the delivery of AZTDP will not lead to increased antiviral activity. It was already reported that in biochemical activity studies using nucleoside diphosphate kinase (NDP-K), which is generally the enzyme that is involved in the phosphorylation of nucleoside diphosphates into their triphosphate forms, the phosphorylation to AZTTP was rather poor. 27 So maybe there is not only a bottleneck in the metabolism of AZTMP to AZTDP 28 but also a bottleneck in the conversion of AZTDP to form AZTTP which becomes more prominent if the concentration of AZTDP is increased because of its delivery from a prodrug. From our studies in CEM/0 cell extracts we clearly have proven that the exclusively formed product from the prodrug was AZTDP. a Antiviral activity in CEM T-lymphocyte cultures: 50% effective concentration. b Cytostatic activity: 50% cytostatic concentration to inhibit CEM/0 cell proliferation by 50%.
Article ■ SUMMARY AND CONCLUSION Nonsymmetric DiPPro-NDPs 1 of the anti-HIV active nucleoside analogues d4T and AZT are disclosed here bearing two different masking units attached to the β-phosphate group of the corresponding nucleoside diphosphate. For the synthesis of the title compounds, a new protocol for the synthesis of nonsymmetric bis(acyloxybenzyl)phosphoramidites was developed, which yielded the phosphoramidites in high chemical yields. These were coupled by weak acid catalysis with nucleoside monophosphates followed by oxidation. By use of this route, DiPPro-d4TDP and DiPPro-AZTDP compounds with different combinations of aliphatic and aromatic acyl moieties were obtained in good yields. Hydrolysis studies in phosphate buffer, RPMI-culture medium, CEM/0 cell extracts, and pig liver esterase confirmed the designed delivery mechanism described above. Half-lives in PBS and RPMIculture medium were markedly higher than those in CEM/0 cell extracts and incubations with PLE. Although in PBS still both the nucleoside diphosphates and the monophosphates were formed, the exclusive products formed by enzymatic hydrolysis of the prodrugs (cell extracts and PLE) were the nucleoside diphosphates. As compared to the symmetric DiPPro-NDPs with two identical masks reported previously, the ratio of formed NDP to NMP was markedly higher in all media. Most of the nonsymmetric DiPPro compounds were as active as or even more active than the corresponding parent nucleosides in wild-type CEM/0 cell cultures. Moreover, also high activities were obtained depending on the lipophilicity of the DiPPro-d4TDP prodrugs against HIV-2 in mutant CEM/ TK − cell cultures. This confirmed that these compounds were efficiently taken up by the cells and delivered intracellularly a phosphorylated form of d4T, most likely d4T diphosphate. Surprisingly, the good antiviral activities of DiPPro-AZTDPs in the wild-type cell cultures were only weakly retained in the mutant TK-deficient cell cultures. This may point to a possible further bottleneck in the phosphorylation of the AZTDP to AZTTP. A clear conclusion from the antiviral activity data was that DiPPro compounds bearing short acetyl ester or benzoyl ester groups in one of the prodrug moieties were not suitable for further development. The first ester group is cleaved too fast and is not lipophilic enough to allow a successful uptake into the target cells, while the second type of ester moiety is also not lipophilic enough although we have shown before that the stability of such compounds could be adjusted over a wide range. 26 Nevertheless, this report on nonsymmetric DiPPro compounds proved the successful and selective nucleoside diphosphate delivery as a further development of the DiPProapproach.
■ EXPERIMENTAL SECTION
General. All experiments involving water-sensitive compounds were conducted under anhydride conditions and nitrogen atmosphere. All solvents were dried over an appropriate drying agent. Triethylamine and acetonitrile were dried by heating under reflux over calcium hydride for several days followed by distillation. Acetonitrile was stored over 3 Å molecular sieves. THF was dried by heating under reflux over potassium followed by distillation. Petroleum ether 50−70 for chromatography was distilled before use. The evaporation of solvents was carried out on a rotary evaporator under reduced pressure or using a high-vacuum pump. Preparative radial chromatography was performed by chromatotron (Harrison Research, model 7924T) with glass plates coated with 1, 2, or 4 mm layers of VWR 60 PF 254 silica gel containing a fluorescent indicator (VWR no. 7749). Analytical thinlayer chromatography was performed on precoated aluminum plates with a 0.2 mm layer of silica gel containing a fluorescent indicator (Macherey & Nagel Xtra Sil UV 254 ); sugar-containing compounds were visualized by wetting the plates with 10% sulfuric acid in water and heating with a fan.
Instrumentation. 1 H NMR spectroscopy was carried out using a Bruker AMX 400 or AV 400 at 400 MHz or a Bruker AV 600 at 600 MHz with CDCl 3 or MeOD-d 4 as internal standards. 13 C NMR spectra were recorded on a Bruker AMX 400 or AV 400 at 101 MHz or on a Bruker AV 600 at 150 MHz (CDCl 3 or MeOD-d 4 as internal standard). 31 P NMR spectra were recorded on a Bruker AMX 400 at 162 MHz or a Bruker AV 600 at 243 MHz (H 3 PO 4 as internal standard). 19 F NMR spectra were recorded on a Bruker AV 600 MHz. All 1 H, 31 P, and 13 C NMR chemical shifts are quoted in parts per million (ppm). All 13 C and 31 P NMR spectra were recorded in the proton-decoupled mode. High resolution ESI mass spectra were recorded with an Agilent 6224 ESI-TOF spectrometer in positive or negative modes. MALDI mass spectra were recorded on an ultrafleXtreme MALDI-TOF-TOF mass spectrometer by Bruker Daltonik with 9-AA as matrix. All HPLC measurements were carried out using a VWR Hitachi Synthesis. General Procedure A. Preparation of Acyloxybenzyl Bis(diisopropylamino)phosphoramidite 6. To a low concentrated solution of 1 equiv of phosphorus trichloride and 1 equiv of pyridine in THF, 1 equiv of 4-acyloxybenzyl alcohol dissolved in THF was added dropwise over 1.5 h at −78°C. After removal of the cold bath the reaction was stirred for about 20 h at room temperature until the total reaction of 4-acyloxybenzyl alcohol was accomplished. Then an amount of 6.1 equiv of N,N-diisopropylamine was added dropwise at −10°C. After removal of the cold bath the reaction was stirred for about 1−2 days at room temperature. Salts were removed by filtration. The crude product was purified by radial chromatography at the chromatotron with petroleum ether/triethylamine as eluent.
General Procedure B. Preparation of Nonsymmetric Bis-(acyloxybenzyl)phosphoramidites 5. To a solution of 1.5 equiv of phosphordiamidite in acetonitrile, 1 equiv of 4-acyloxybenzyl alcohol and 1 equiv of a DCI-activator solution (0.25 M in acetonitrile) also dissolved in acetonitrile were added dropwise at 4°C. After removal of the cold bath the reaction mixture was stirred for 30−60 min. The reaction was stopped by removing the solvent under reduced pressure. The residue was dissolved in petroleum ether/triethylamine (9:1) and filtered. The crude product was purified by radial chromatography at the chromatotron with petroleum ether/triethylamine as eluent.
General Procedure C. Preparation of DiPPro-Nucleoside Diphosphates. An amount of 1.5 equiv of phosphoramidite 5 was added to a solution of 1 equiv of the bis(tetra-n-butylammonium) nucleoside monophosphate in acetonitrile. The reaction was started by addition of 0.5 equiv of 4,5-dicyanoimidazole (0.25 M solution in acetonitrile) at room temperature. Every 5 min again 0.25 equiv of 4,5-dicyanoimidazole was added up to a total of 1.25−1.75 equiv. After stirring another 5 min after the last addition, the mixture was oxidized by addition of 1.5 equiv of tert-butyl hydroperoxide (5.5 M solution in n-decane). The solvents were removed under reduced pressure after 15 min. The compounds were isolated by automatic flash RP18-chromatography (acetonitrile/water). After the tetra-n-butylammonium ions were changed with ammonia by elution over DOWEX . Syntheses of symmetric bis(4-pentanoyloxymethyl)-, bis(4-heptan oy l ox y m e t hy l ) -, a n d b i s ( 4 -de c a n oy l o xy m e t hy l ) -N , Ndiisopropylaminophosphoramidite have been described before. 24, 25 The analytical data were identical.
Ammonium-CH 3 /C 7 H 15 -DiPPro-d4TDP 7a. General procedure E; phosphoramidite 5a (144 mg, 0.26 mmol), d4T monophosphate (110 mg, 0.18 mmol), and 4,5-dicyanoimidazole activator solution (1.04 μL, 0.26 mmol) in 4 mL of acetonitrile. Oxidation by addition of tert-butyl hydroperoxide (5.5 M solution in n-decane, 47 μL, 0.26
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Article mmol). The product (108 mg, 0.14 mmol, 79%) was obtained as a colorless wad after ion exchange. 1 Ammonium-C 4 H 9 /CH 3 -Ph-DiPPro-d4TDP 8e. General procedure E; phosphoramidite 5j (123 mg, 0.21 mmol), d4T monophosphate (89 mg, 0.14 mmol), and 4,5-dicyanoimidazole activator solution (860 μL, 0.21 mmol) in 4 mL of acetonitrile. Oxidation by addition of tert-butyl hydroperoxide (5.5 M solution in n-decane, 39 μL, 0.21 mmol). The product (36 mg, 0.044 mmol, 31%) was obtained as a colorless wad after ion exchange. 1 Ammonium-CH 3 /C 9 H 19 -DiPPro-AZTDP 9b. General procedure E; phosphoramidite 5b (100 mg, 0.18 mmol), AZT monophosphate (73 mg, 0.12 mmol), and 4,5-dicyanoimidazole activator solution (700 μL, 0.18 mmol) in 3 mL of acetonitrile. Oxidation by addition of tertbutyl hydroperoxide (5.5 M solution in n-decane, 32 μL, 0.18 mmol). The product (45 mg, 0.053 mmol, 45%) was obtained as a colorless wad after ion exchange.
Hydrolysis Studies in CEM/0 Cell Extracts. An amount of 50 μL CEM/0 cell extracts was mixed with 10 μL of water. By addition of 10 μL of a 6 mM solution of the DiPPro-NDP in DMSO, the hydrolysis was started. Six to eight of these samples were prepared and incubated at 37°C for different periods of time. Hydrolysis was stopped by quenching with 150 μL of methanol. After 5 min on ice, 5 min in an ultrasonic bath, and centrifugation at 13 000 rpm (Heraeus, Biofuge Pico) the samples were filtered and frozen in liquid nitrogen until an amount of 35 μL was injected into the analytical RP-18-HPLC instrument. Hydrolysis was monitored for a maximum of 10 h.
Hydrolysis Studies in RPMI Medium. An amount of 50 μL of RPMI-culture medium without FCS was mixed with 10 μL of water. By addition of 10 μL of a 6 mM solution of the DiPPro-NDP in DMSO, the hydrolysis was started. Six to eight of these samples were prepared and incubated at 37°C for different periods of time. After a period of time an amount of 150 μL of methanol was added and the sample was frozen in liquid nitrogen until an amount of 35 μL was injected into the analytical RP-18-HPLC instrument.
Hydrolysis Studies with PLE. An amount of 10 μL of a 6 mM solution of the DiPPro-NDP in DMSO was mixed with 15 μL of DMSO and 100 μL of 50 mM phosphate buffer. By addition of 7.5 μL of PLE solution (3 mg/mL in PBS, 17 units/mg), the hydrolysis was started. Hydrolysis was stopped by quenching with 132.5 μL of methanol. After 5 min on ice, 5 min in an ultrasonic bath, and centrifugation at 13 000 rpm (Heraeus, Biofuge Pico) the samples were filtered and frozen in liquid nitrogen until an amount of 35 μL was injected into the analytical RP-18-HPLC instrument.
Preparation of CEM Cell Extracts. Human CD4 + T-lymphocyte CEM cells were grown in RPMI-1640-based cell culture medium to a final density of about 3 × 10 6 cells/mL. After centrifugation for 10 min at 1250 rpm (Heraeus, Megafuge 3.0R) at 4°C, washing twice with cold phosphate buffered saline (PBS), the pellet was resuspended at 10 8 cells/mL and sonicated three times for 10 s. After a second centrifugation of this suspension at 10 000 rpm (Heraeus, Megafuge 3.0R) the supernatant was divided into aliquots and frozen to −80°C until used.
Antiviral Assay. Inhibition of HIV-1(III B )-and HIV-2(ROD)-induced cytopathogenicity in wild-type CEM/0 or thymidine kinasedeficient CEM/TK − cell cultures was measured in microtiter 96-well plates containing ∼3 × 10 5 CEM cells/mL infected with 100 CCID 50 of HIV per milliliter and containing appropriate dilutions of the test compounds. After 4−5 days of incubation at 37°C in a CO 2 -controlled humidified atmosphere, CEM giant (syncytium) cell formation was examined microscopically. EC 50 (50% effective concentration) was defined as the compound concentration required to inhibit HIV-induced giant cell formation by 50%.
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